TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,019
|
7,050
|
8,365 |
Financial expenses |
806
|
446
|
238 |
Earnings before taxes |
-3,570
|
-4,781
|
-3,178 |
EBITDA |
-1,786
|
-3,614
|
-2,230 |
Total assets |
15,191
|
14,335
|
13,925 |
Current assets |
7,800
|
8,074
|
7,241 |
Current liabilities |
11,869
|
12,630
|
12,734 |
Equity capital |
3,322
|
1,705
|
1,190 |
- share capital |
18
![]() |
18
|
20 |
Employees (average) |
99
|
105
|
97 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.9%
|
11.9%
|
8.5% |
Turnover per employee |
91
|
67
|
86 |
Profit as a percentage of turnover |
-39.6%
|
-67.8%
|
-38.0% |
Return on assets (ROA) |
-18.2%
|
-30.2%
|
-21.1% |
Current ratio |
65.7%
|
63.9%
|
56.9% |
Return on equity (ROE) |
-107.5%
|
-280.4%
|
-267.1% |
Change turnover |
1,948
|
-637
|
-4,366 |
Change turnover % |
28%
|
-8%
|
-34% |
Chg. No. of employees |
-6
|
8
|
6 |
Chg. No. of employees % |
-6%
|
8%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.